{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:23:20Z","timestamp":1781850200885,"version":"3.54.5"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s40620-020-00916-9","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T10:07:49Z","timestamp":1609754869000},"page":"1189-1199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Disorders in bone-mineral parameters and the risk of death in persons with chronic kidney disease stages 4 and 5: the PECERA study"],"prefix":"10.1093","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8311-6214","authenticated-orcid":false,"given":"Pablo","family":"Molina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola D.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Pallard\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Torralba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"S\u00e1nchez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Gonz\u00e1lez-Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Puchades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 E.","family":"Fern\u00e1ndez-N\u00e1jera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gim\u00e9nez-Civera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"D\u2019Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"G\u00f3rriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"issue":"5","key":"916_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11914-019-00533-x","volume":"17","author":"E Bellorin-Font","year":"2019","unstructured":"Bellorin-Font E, Vasquez-Rios G, Martin KJ (2019) Controversies in the management of secondary hyperparathyroidism in chronic kidney disease. Curr Osteoporos Rep 17(5):333\u2013342. https:\/\/doi.org\/10.1007\/s11914-019-00533-x","journal-title":"Curr Osteoporos Rep"},{"key":"916_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfz187","author":"J Bover","year":"2020","unstructured":"Bover J, Ure\u00f1a-Torres P, Mateu S et al (2020) Evidence in chronic kidney disease-mineral and bone disorder guidelines: is it time to treat or time to wait? Clin Kidney J. https:\/\/doi.org\/10.1093\/ckj\/sfz187 ([published online ahead of print, 2020 Jan 15])","journal-title":"Clin Kidney J"},{"issue":"2","key":"916_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.semnephrol.2014.02.007","volume":"34","author":"P Evenepoel","year":"2014","unstructured":"Evenepoel P, Rodriguez M, Ketteler M (2014) Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease? Semin Nephrol 34(2):151\u2013163. https:\/\/doi.org\/10.1016\/j.semnephrol.2014.02.007","journal-title":"Semin Nephrol"},{"issue":"6","key":"916_CR4","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","volume":"90","author":"P Evenepoel","year":"2016","unstructured":"Evenepoel P, Bover J, Ure\u00f1a-Torres P (2016) Parathyroid hormone metabolism and signaling in health and chronic kidney disease. Kidney Int 90(6):1184\u20131190","journal-title":"Kidney Int"},{"issue":"6","key":"916_CR5","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/sdi.12411","volume":"28","author":"AJ Felsenfeld","year":"2015","unstructured":"Felsenfeld AJ, Levine BS, Rodriguez M (2015) Pathophysiology of calcium, phosphorus, and magnesium dysregulation in chronic kidney disease. Semin Dial 28(6):564\u2013577","journal-title":"Semin Dial"},{"issue":"9","key":"916_CR6","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","volume":"30","author":"JL Fern\u00e1ndez-Mart\u00edn","year":"2015","unstructured":"Fern\u00e1ndez-Mart\u00edn JL, Mart\u00ednez-Camblor P, Dionisi MP et al (2015) Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transplant 30(9):1542\u20131551","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"916_CR7","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/ckj\/sfy015","volume":"11","author":"D Fouque","year":"2018","unstructured":"Fouque D, Roth H, Darn\u00e9 B et al (2018) Achievement of 2009 and 2017 kidney disease: improving global outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease stages 4 and 5 non-dialysis patients. Clin Kidney J 11(5):710\u2013719","journal-title":"Clin Kidney J"},{"issue":"7","key":"916_CR8","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/ndt\/gfq650","volume":"26","author":"C Garc\u00eda-Canton","year":"2011","unstructured":"Garc\u00eda-Canton C, Bosch E, Ram\u00edrez A et al (2011) Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant 26(7):2250\u20132256","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"916_CR9","first-page":"46","volume":"33","author":"JL G\u00f3rriz","year":"2013","unstructured":"G\u00f3rriz JL, Molina P, Bover J et al (2013) Characteristics of bone mineral metabolism in patients with stage 3\u20135 chronic kidney disease not on dialysis: results of the OSERCE study. Nefrologia 33(1):46\u201360","journal-title":"Nefrologia"},{"issue":"4","key":"916_CR10","doi-asserted-by":"publisher","first-page":"654","DOI":"10.2215\/CJN.07450714","volume":"10","author":"JL G\u00f3rriz","year":"2015","unstructured":"G\u00f3rriz JL, Molina P, Cerver\u00f3n MJ et al (2015) Vascular calcification in patients with nondialysis CKD over 3 years. Clin J Am Soc Nephrol 10(4):654\u2013666","journal-title":"Clin J Am Soc Nephrol"},{"key":"916_CR11","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Guti\u00e9rrez","year":"2009","unstructured":"Guti\u00e9rrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G et al (2009) Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119:2545\u20132552","journal-title":"Circulation"},{"issue":"1","key":"916_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/0141076814562718","volume":"108","author":"AB Hill","year":"2015","unstructured":"Hill AB (2015) The environment and disease: association or causation? 1965. J R Soc Med 108(1):32\u201337","journal-title":"J R Soc Med"},{"issue":"2","key":"916_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1053\/j.ajkd.2019.07.022","volume":"75","author":"T Isakova","year":"2020","unstructured":"Isakova T, Cai X, Lee J et al (2020) Longitudinal evolution of markers of mineral metabolism in patients with CKD: the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis 75(2):235\u2013244. https:\/\/doi.org\/10.1053\/j.ajkd.2019.07.022","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"916_CR14","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1681\/ASN.2004070602","volume":"16","author":"B Kestenbaum","year":"2005","unstructured":"Kestenbaum B, Sampson JN, Rudser KD et al (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16(2):520\u2013528","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"916_CR15","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1681\/ASN.2004070602","volume":"16","author":"B Kestenbaum","year":"2005","unstructured":"Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16(2):520\u2013528. https:\/\/doi.org\/10.1681\/ASN.2004070602","journal-title":"J Am Soc Nephrol"},{"key":"916_CR16","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.2215\/CJN.02160212","volume":"7","author":"AM Khan","year":"2012","unstructured":"Khan AM, Chirinos JA, Litt H, Yang W, Rosas SE (2012) FGF-23 and the progression of coronary arterial calcification in patients new to dialysis. Clin J Am Soc Nephrol 7:2017\u20132022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"916_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"Kidney Disease :Improving Global Outcomes (KDIGO) CKD-MKD Update Work Group","year":"2017","unstructured":"Kidney Disease\u202f:Improving Global Outcomes (KDIGO) CKD-MKD Update Work Group (2017) KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7(1):1\u201359","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"916_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s11255-008-9346-7","volume":"40","author":"CP Kovesdy","year":"2008","unstructured":"Kovesdy CP, Kalantar-Zadeh K (2008) Bone and mineral disorders in pre-dialysis CKD. Int Urol Nephrol 40(2):427\u2013440","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"916_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.5414\/CNP73268","volume":"73","author":"CP Kovesdy","year":"2010","unstructured":"Kovesdy CP, Anderson JE, Kalantar-Zadeh K (2010) Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease. Clin Nephrol 73(4):268\u2013275","journal-title":"Clin Nephrol"},{"issue":"3","key":"916_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2215\/CJN.06040809","volume":"5","author":"CP Kovesdy","year":"2010","unstructured":"Kovesdy CP, Kuchmak O, Lu JL, Kalantar-Zadeh K (2010) Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol 5(3):468\u2013476","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"916_CR21","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/ndt\/gfz060","volume":"35","author":"C Lamina","year":"2020","unstructured":"Lamina C, Kronenberg F, Stenvinkel P et al (2020) Association of changes in bone mineral parameters with mortality in haemodialysis patients: insights from the ARO cohort. Nephrol Dial Transplant 35(3):478\u2013487","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"916_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612","journal-title":"Ann Intern Med"},{"issue":"1","key":"916_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2007","unstructured":"Levin A, Bakris GL, Molitch M et al (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71(1):31\u201338","journal-title":"Kidney Int"},{"key":"916_CR24","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1016\/j.csda.2008.12.008","volume":"53","author":"EJ Malloy","year":"2009","unstructured":"Malloy EJ, Spiegelman D, Eisen EA (2009) Comparing measures of model selection for penalized splines in Cox models. Comput Stat Data Anal 53:2605\u20132616","journal-title":"Comput Stat Data Anal"},{"issue":"4","key":"916_CR25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1053\/j.ackd.2016.03.008","volume":"23","author":"ML Melamed","year":"2016","unstructured":"Melamed ML, Buttar RS, Coco M (2016) CKD-mineral bone disorder in stage 4 and 5 CKD: what we know today? Adv Chronic Kidney Dis 23(4):262\u2013269","journal-title":"Adv Chronic Kidney Dis"},{"issue":"3","key":"916_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1053\/j.ajkd.2005.05.025","volume":"46","author":"V Menon","year":"2005","unstructured":"Menon V, Greene T, Pereira AA et al (2005) Relationship of phosphorus and calcium-phosphorus product with mortality in CKD. Am J Kidney Dis 46(3):455\u2013463. https:\/\/doi.org\/10.1053\/j.ajkd.2005.05.025","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"916_CR27","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1681\/ASN.2005090986","volume":"17","author":"AM O'Hare","year":"2006","unstructured":"O\u2019Hare AM, Bertenthal D, Covinsky KE, Landefeld CS, Sen S, Mehta K, Steinman MA, Borzecki A, Walter LC (2006) Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol 17(3):846\u2013853","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"916_CR28","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/jama.2011.308","volume":"305","author":"S Palmer","year":"2011","unstructured":"Palmer S, Hayen A, Mackaskill P et al (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA 305(11):1119\u20131127","journal-title":"JAMA"},{"issue":"4","key":"916_CR29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2215\/CJN.06620617","volume":"13","author":"S Seiler-Mussler","year":"2018","unstructured":"Seiler-Mussler S, Limbach AS, Emrich IE et al (2018) Association of nonoxidized parathyroid hormone with cardiovascular and kidney disease outcomes in chronic kidney disease. Clin J Am Soc Nephrol 13(4):569\u2013576. https:\/\/doi.org\/10.2215\/CJN.06620617","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"916_CR30","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s11255-018-1906-x","volume":"50","author":"JJB Seng","year":"2018","unstructured":"Seng JJB, Tan YLC, Lim RW et al (2018) Prevalence and risk factors for hypercalcemia among non-dialysis patients with chronic kidney disease-mineral and bone disorder. Int Urol Nephrol. 50(10):1871\u20131877","journal-title":"Int Urol Nephrol."},{"key":"916_CR31","doi-asserted-by":"publisher","unstructured":"Therneau TM, Grambsch PM (2000) The cox model. In: Modeling survival data: extending the cox model statistics for biology and health. Springer, New York, p 39\u201377. . https:\/\/doi.org\/https:\/\/doi.org\/10.1007\/978-1-4757-3294-8_3(ISBN 0-387-98784-3)","DOI":"10.1007\/978-1-4757-3294-8_3"},{"issue":"Suppl 1","key":"916_CR32","first-page":"S1","volume":"28","author":"JV Torregrosa","year":"2008","unstructured":"Torregrosa JV, Cannata-Andia J, Bover J et al (2008) Recommendations of the Spanish Society of Nephrology for managing bone-mineral metabolic alterations in chronic renal disease patients. Nefrologia 28(Suppl 1):S1-22","journal-title":"Nefrologia"},{"issue":"5","key":"916_CR33","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ahj.2013.02.014","volume":"165","author":"AJ van Ballegooijen","year":"2013","unstructured":"van Ballegooijen AJ, Reinders I, Visser M, Brouwer IA (2013) Parathyroid hormone and cardiovascular disease events: a systematic review and meta-analysis of prospective studies. Am Heart J 165(5):655-664.e6645. https:\/\/doi.org\/10.1016\/j.ahj.2013.02.014","journal-title":"Am Heart J"},{"issue":"10","key":"916_CR34","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","volume":"22","author":"N Voormolen","year":"2007","unstructured":"Voormolen N, Noordzij M, Grootendorst DC et al (2007) High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 22(10):2909\u20132916. https:\/\/doi.org\/10.1093\/ndt\/gfm286","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"916_CR35","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","volume":"22","author":"N Voormolen","year":"2007","unstructured":"Voormolen N, Noordzij M, Grootendorst DC, PREPARE study group et al (2007) High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant. 22(10):2909\u20132916. https:\/\/doi.org\/10.1093\/ndt\/gfm286","journal-title":"Nephrol Dial Transplant."},{"issue":"2","key":"916_CR36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2215\/CJN.06240909","volume":"5","author":"R Watanabe","year":"2010","unstructured":"Watanabe R, Lemos MM, Manfredi SR, Draibe SA, Canziani ME (2010) Impact of cardiovascular calcification in nondialyzed patients after 24 months of follow-up. Clin J Am Soc Nephrol 5(2):189\u2013194","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00916-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-020-00916-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00916-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:55:37Z","timestamp":1777564537000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/34\/4\/1189\/8325979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["916"],"URL":"https:\/\/doi.org\/10.1007\/s40620-020-00916-9","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"6 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The results presented in this paper have not been published previously in whole or part, except in abstract format. JJC acknowledges support from the Swedish Research Council (grant number 2019-01059). The authors declare no other conflicts of interest that might be perceived as affecting the objectivity of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was conducted in agreement with the Declaration of Helsinki, and the Hospital Ethics Committees approved the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients provided informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}